JPXGY Financial Statements & Analysis
Complete financial statements for JPXGY including income statement, balance sheet, and cash flow statement. Analyze JPXGY's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
28.6% ↑
Net Income
37.4% ↑
Gross Margin
32.0% ↑
Operating Margin
5.1% ↑
Balance Sheet
Current Ratio
156.8% ↑
Debt to Equity
-1.2% ↑
Asset Turnover
52.7% ↑
Cash Flow
Operating Cash Flow
32.6% ↑
Net Cash Flow
119.5% ↑
Free Cash Flow
59.5% ↑
Cash Flow to Debt
32.0% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2025 | 2026 | Change | Impact |
|---|---|---|---|---|
| Revenue | 164.17B | 211.05B | 28.6% | |
| Gross Profit | 89.09B | 151.15B | 69.7% | |
| Operating Income | 90.12B | 121.74B | 35.1% | |
| Net Income | 61.09B | 83.91B | 37.4% | |
| EPS | 58.72 | 81.49 | 38.8% | |
| EBITDA | 108.81B | 143.41B | 31.8% | |
| Gross Margin | 54.26% | 71.62% | 32.0% | |
| Operating Margin | 54.89% | 57.68% | 5.1% | |
| Net Income Margin | 37.21% | 39.76% | 6.8% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 211.05B | 164.17B | 157.80B | — | — |
| Gross Profit | 151.15B | 89.09B | 86.02B | — | — |
| Operating Income | 121.74B | 90.12B | 87.44B | — | — |
| Net Income | 83.91B | 61.09B | 60.82B | — | — |
| EPS | 81.49 | 58.72 | 58.45 | — | — |
| EBITDA | 143.41B | 108.81B | 105.81B | — | — |
| Gross Margin | 71.62% | 54.26% | 54.51% | — | — |
| Operating Margin | 57.68% | 54.89% | 55.41% | — | — |
| Net Income Margin | 39.76% | 37.21% | 38.54% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into JPXGY's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics